Julia Huber

1.3k total citations
31 papers, 1.1k citations indexed

About

Julia Huber is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Julia Huber has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Oncology and 7 papers in Surgery. Recurrent topics in Julia Huber's work include Cancer Cells and Metastasis (9 papers), 3D Printing in Biomedical Research (6 papers) and Cholesterol and Lipid Metabolism (4 papers). Julia Huber is often cited by papers focused on Cancer Cells and Metastasis (9 papers), 3D Printing in Biomedical Research (6 papers) and Cholesterol and Lipid Metabolism (4 papers). Julia Huber collaborates with scholars based in Austria, Switzerland and Germany. Julia Huber's co-authors include Alexander R. Rosenkranz, Kathrin Eller, Gert Mayer, Arno Amann, Gabriele Gamerith, H. Zwierzina, Jens M. Kelm, Wolfgang Hilbe, Anna Wolf and Anikó Szabó and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Julia Huber

31 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia Huber Austria 17 377 362 228 176 154 31 1.1k
João Incio United States 9 458 1.2× 434 1.2× 311 1.4× 248 1.4× 179 1.2× 13 1.3k
Daniëlle Raats Netherlands 15 391 1.0× 325 0.9× 158 0.7× 95 0.5× 154 1.0× 28 818
Gang Xiao China 20 501 1.3× 376 1.0× 197 0.9× 54 0.3× 209 1.4× 63 1.1k
Manuel Pérez‐Martínez Spain 13 494 1.3× 294 0.8× 325 1.4× 64 0.4× 144 0.9× 23 1.1k
Nicole Parker Australia 10 388 1.0× 391 1.1× 165 0.7× 81 0.5× 276 1.8× 16 1.1k
R. K. Jain India 11 525 1.4× 557 1.5× 190 0.8× 98 0.6× 226 1.5× 30 1.2k
Paolo Esposto Pirani Italy 15 347 0.9× 651 1.8× 387 1.7× 107 0.6× 136 0.9× 31 1.3k
Matthew R. Eber United States 16 354 0.9× 614 1.7× 180 0.8× 72 0.4× 275 1.8× 29 1.1k
Donata Simińska Poland 11 439 1.2× 345 1.0× 385 1.7× 92 0.5× 281 1.8× 19 1.2k
Anh N. Diep United States 12 422 1.1× 272 0.8× 269 1.2× 60 0.3× 293 1.9× 17 893

Countries citing papers authored by Julia Huber

Since Specialization
Citations

This map shows the geographic impact of Julia Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Huber more than expected).

Fields of papers citing papers by Julia Huber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Huber. The network helps show where Julia Huber may publish in the future.

Co-authorship network of co-authors of Julia Huber

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Huber. A scholar is included among the top collaborators of Julia Huber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Huber. Julia Huber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pfeiffer, Christina, Hélène Asnagli, Julia Huber, et al.. (2023). CTPS1 is a novel therapeutic target in multiple myeloma which synergizes with inhibition of CHEK1, ATR or WEE1. Leukemia. 38(1). 181–192. 10 indexed citations
2.
Bronsert, Peter, Andrew Fuller, Andrew Filby, et al.. (2021). Multiple Immunostainings with Different Epitope Retrievals—The FOLGAS Protocol. International Journal of Molecular Sciences. 23(1). 223–223. 4 indexed citations
3.
Salcher, Stefan, Gilles A. Spoden, Julia Huber, et al.. (2019). Repaglinide Silences the FOXO3/Lumican Axis and Represses the Associated Metastatic Potential of Neuronal Cancer Cells. Cells. 9(1). 1–1. 119 indexed citations
4.
Amann, Arno, Marit Zwierzina, Gabriele Gamerith, et al.. (2017). Development of a 3D angiogenesis model to study tumour – endothelial cell interactions and the effects of anti-angiogenic drugs. Scientific Reports. 7(1). 2963–2963. 53 indexed citations
5.
Zwierzina, Marit, Julia Huber, Mario Bitsche, et al.. (2016). Infiltration of lymphocyte subpopulations into cancer microtissues as a tool for the exploration of immunomodulatory agents and biomarkers. Immunobiology. 221(5). 604–617. 6 indexed citations
6.
Lebok, Patrick, Julia Huber, Annette Lebeau, et al.. (2016). Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer. Molecular Medicine Reports. 14(2). 1443–1450. 8 indexed citations
7.
Huber, Julia, Arno Amann, Edith Lorenz, et al.. (2016). Evaluation of assays for drug efficacy in a three-dimensional model of the lung. Journal of Cancer Research and Clinical Oncology. 142(9). 1955–1966. 33 indexed citations
8.
Gamerith, Gabriele, Johannes Rainer, Arno Amann, et al.. (2015). Abstract 326: Differences in RNA expression and chemosensitivity in 2D versus 3D non-small-cell lung cancer cultures. Cancer Research. 75(15_Supplement). 326–326. 1 indexed citations
9.
Amann, Arno, Marit Zwierzina, Gabriele Gamerith, et al.. (2014). Development of an Innovative 3D Cell Culture System to Study Tumour - Stroma Interactions in Non-Small Cell Lung Cancer Cells. PLoS ONE. 9(3). e92511–e92511. 130 indexed citations
10.
Eller, Kathrin, Andrea Schroll, Alexander H. Kirsch, et al.. (2013). Lipocalin-2 Expressed in Innate Immune Cells Is an Endogenous Inhibitor of Inflammation in Murine Nephrotoxic Serum Nephritis. PLoS ONE. 8(7). e67693–e67693. 40 indexed citations
11.
Tancevski, Ivan, Egon Demetz, Kathrin Eller, et al.. (2010). The Liver-Selective Thyromimetic T-0681 Influences Reverse Cholesterol Transport and Atherosclerosis Development in Mice. PLoS ONE. 5(1). e8722–e8722. 43 indexed citations
12.
Eller, Kathrin, Dominik Wolf‎, Julia Huber, et al.. (2010). IL-9 Production by Regulatory T Cells Recruits Mast Cells That Are Essential for Regulatory T Cell-Induced Immune Suppression. The Journal of Immunology. 186(1). 83–91. 147 indexed citations
13.
Schroll, Andrea, Kathrin Eller, Julia Huber, et al.. (2010). Tim3 Is Upregulated and Protective in Nephrotoxic Serum Nephritis. American Journal Of Pathology. 176(4). 1716–1724. 18 indexed citations
14.
Huber, Julia, et al.. (2009). The proteasome inhibitor Bortezomib aggravates renal ischemia-reperfusion injury. American Journal of Physiology-Renal Physiology. 297(2). F451–F460. 26 indexed citations
15.
Wehinger, Andreas, Ivan Tancevski, Sandra Frotschnig, et al.. (2009). Influence of aspirin on SR-BI expression in human carotid plaques. Atherosclerosis. 206(1). 234–238. 5 indexed citations
16.
Hochegger, Kathrin, Kathrin Eller, Julia Huber, et al.. (2007). Expression of granzyme A in human polymorphonuclear neutrophils. Immunology. 121(2). 166–173. 18 indexed citations
17.
Tancevski, Ivan, Andreas Wehinger, Egon Demetz, et al.. (2006). Hyperthyroidism decreases plasma HDL cholesterol by inhibition of hepatic ABCA1 expression. Data Archiving and Networked Services (DANS). 1 indexed citations
18.
Hochegger, Kathrin, Christian Koppelstaetter, Andrea Tagwerker, et al.. (2006). p21 and mTERT are novel markers for determining different ischemic time periods in renal ischemia-reperfusion injury. American Journal of Physiology-Renal Physiology. 292(2). F762–F768. 35 indexed citations
19.
Dalmau, Josep, et al.. (1995). Paraneoplastic Encephalomyelitis Antigens Bind to the AU-rich Elements of mRNA. Neurology. 45(3). 544–550. 109 indexed citations
20.
Huber, Julia, et al.. (1990). Hereditary cancer and its clinical implications: a view.. PubMed. 10(2B). 489–95. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026